P.2.f.027 The efficacy and safety of basimglurant as adjunctive therapy in major depression; a randomised, double-blind, placebo-controlled study
Quiroz, J.A, Tamburri, P, Deptula, D, Banken, L, Beyer, U, Fontoura, P, Santarelli, L
Published in European neuropsychopharmacology (01.10.2014)
Published in European neuropsychopharmacology (01.10.2014)
Get full text
Journal Article
238P NMD670, a first-in-class skeletal muscle ClC-1 Inhibitor in myasthenia gravis: the SYNAPSE-MG dose-finding study
Gidaro, T., Grønnebæk, T.S., Cornwall, C., Gupte, J., Sampson, C., Kiyasova, V., Pedersen, T.H., Quiroz, J.A.
Published in Neuromuscular disorders : NMD (01.10.2024)
Published in Neuromuscular disorders : NMD (01.10.2024)
Get full text
Journal Article
103P NMD670, a first-in-class skeletal muscle ClC-1 Inhibitor in Charcot-Marie-Tooth disease: the SYNAPSE-CMT phase 2 study
Gidaro, T., Grønnebæk, T.S., Cornwall, C., Gupte, J., Sampson, C., Kiyasova, V., Pedersen, T.H., Quiroz, J.A.
Published in Neuromuscular disorders : NMD (01.10.2024)
Published in Neuromuscular disorders : NMD (01.10.2024)
Get full text
Journal Article